Sasaki Akira, Yokote Koutaro, Naitoh Takeshi, Fujikura Junji, Hayashi Karin, Hirota Yushi, Inagaki Nobuya, Ishigaki Yasushi, Kasama Kazunori, Kikkawa Eri, Koyama Hidenori, Masuzaki Hiroaki, Miyatsuka Takeshi, Nozaki Takehiro, Ogawa Wataru, Ohta Masayuki, Okazumi Shinichi, Shimabukuro Michio, Shimomura Iichiro, Nishizawa Hitoshi, Saiki Atsuhito, Seki Yosuke, Shojima Nobuhiro, Tsujino Motoyoshi, Ugi Satoshi, Watada Hiroaki, Yamauchi Toshimasa, Yamaguchi Takashi, Ueki Kohjiro, Kadowaki Takashi, Tatsuno Ichiro
Department of Surgery, Iwate Medical University, 2-1-1 Idaidori, Yahaba, 028-3695 Japan.
Department of Endocrinology Hematology, and Gerontology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Diabetol Int. 2021 Nov 8;13(1):1-30. doi: 10.1007/s13340-021-00551-0. eCollection 2022 Jan.
Bariatric surgery has been shown to have a variety of metabolically beneficial effects for patients with type 2 diabetes (T2D), and is now also called metabolic surgery. At the 2nd Diabetes Surgery Summit held in 2015 in London, the indication for bariatric and metabolic surgery was included in the "algorithm for patients with type T2D". With this background, the Japanese Society for Treatment of Obesity (JSTO), the Japan Diabetes Society (JDS) and the Japan Society for the Study of Obesity (JASSO) have formed a joint committee to develop a consensus statement regarding bariatric and metabolic surgery for the treatment of Japanese patients with T2D. Eventually, the consensus statement was announced at the joint meeting of the 38th Annual Meeting of JSTO and the 41st Annual Meeting of JASSO convened in Toyama on March 21, 2021. In preparing the consensus statement, we used Japanese data as much as possible as scientific evidence to consider the indication criteria, and set two types of recommendation grades, "recommendation" and "consideration", for items for which recommendations are possible. We hope that this statement will be helpful in providing evidence-based high-quality care through bariatric and metabolic surgery for the treatment of obese Japanese patients with T2D.
The online version contains supplementary material available at 10.1007/s13340-021-00551-0.
减肥手术已被证明对2型糖尿病（T2D）患者具有多种代谢有益作用，现在也被称为代谢手术。在2015年于伦敦举行的第二届糖尿病手术峰会上，减肥和代谢手术的适应症被纳入了“T2D患者算法”中。在此背景下，日本肥胖治疗学会（JSTO）、日本糖尿病学会（JDS）和日本肥胖研究学会（JASSO）成立了一个联合委员会，以制定关于减肥和代谢手术治疗日本T2D患者的共识声明。最终，该共识声明在2021年3月21日于富山召开的JSTO第38届年会和JASSO第41届年会的联合会议上公布。在编写共识声明时，我们尽可能多地使用日本数据作为科学证据来考虑适应症标准，并为可能提出建议的项目设定了“推荐”和“考虑”两种推荐等级。我们希望本声明将有助于通过减肥和代谢手术为肥胖的日本T2D患者提供基于证据的高质量护理。
在线版本包含可在10.1007/s13340-021-00551-0获取的补充材料。
